European Platform on Innovative Medicines
The overall objective of the platform is to remove bottlenecks hampering the efficiency of the development of new medicines, and where research is the key to resolve current obstacles for the European pharma/biotechnology industry to become world leaders.
Read more here.
Source: European Commission
ScanBalt News
3 September 2024
LSX Nordic Congress 2024 | 8-9 October | Copenhagen, Denmark